Last Friday (4/23), the CDC’s Advisory Committee on Immunization Practices (ACIP), reviewed 15 cases of rare blood clots, thrombosis with thrombocytopenia syndrome (TTS), that occurred following administration of the Janssen (Johnson & Johnson) COVID-19 vaccine.
ACIP voted 10-4 to recommend lifting the temporary, 10-day pause of use of the J&J vaccine. Following that recommendation, CDC and FDA lifted the pause.
Tomorrow (4/27), CDC’s Clinician Outreach and Communication Activity (COCA) Call will discuss information on TTS and updated vaccine recommendations. This webinar is scheduled for Tuesday, April 27 from 2:00 - 3:00pm Eastern Time.
These TTS cases were detected through the Vaccine Adverse Events Reporting System (VAERS). Reminder that healthcare providers are required by law to report any adverse event to VAERS.
This project was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000580). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this resource center do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.